Differential Pharmacodynamic Effects on Psoriatic Biomarkers by Guselkumab Versus Secukinumab Correlate with Long-Term Efficacy: An ECLIPSE Substudy

Category Primary study
JournalJID Innovations
Year 2024
This article has no abstract
Epistemonikos ID: 1d9f8669f2a6817274ea3947be398d3426cffa89
First added on: Feb 18, 2025